Objective To determine the effect of prophylactic dextrose gel for prevention of neonatal
hypoglycaemia on neurodevelopment and executive function at 2 years' corrected age …

Objective To investigate the effect of different doses of prophylactic dextrose gel on
neurocognitive function and health at 6–7 years. Design Early school-age follow-up of the …

Background Neonatal hypoglycaemia is common, affecting up to 15% of newborns, and can
cause brain damage. Currently, there are no strategies, beyond early feeding, to prevent …

Importance Prophylactic oral dextrose gel reduces neonatal hypoglycemia, but later benefits
or harms remain unclear. Objective To assess the effects on later development of …

Background Neonatal hypoglycemia is common and can cause brain injury. Buccal dextrose
gel is effective for treatment of neonatal hypoglycemia, and when used for prevention may …

Objective To determine neurodevelopmental outcome at 2 years' corrected age in children
randomized to treatment with dextrose gel or placebo for hypoglycemia soon after birth (The …

Background Neonatal hypoglycaemia is common, affecting up to 15% of newborn babies
and 50% of those with risk factors (preterm, infant of a diabetic, high or low birthweight) …

Objective To test the hypothesis that prophylactic dextrose gel administered to newborn
infants at risk for hypoglycemia will increase the initial blood glucose concentration after the …

Introduction: Dextrose gel is widely used as first-line treatment for neonatal hypoglycaemia
given its cost-effectiveness and ease of use. The Sugar Babies randomized trial first showed …

Objective Dextrose gel is used to treat neonatal hypoglycaemia, but later effects are
unknown. Design and setting Follow-up of participants in a randomised trial recruited in a …